The role of interpersonal relationships in men's attendance in primary care: Qualitative findings in a cohort of men with prostate cancer

Supportive Care in Cancer

Volumn 22, Issue 2, 2014, Pages 409-415

  Forbat, Liz ^a   Place, Morag ^a   Hubbard, Gill ^a   Leung, Hing ^b   Kelly, Daniel ^c  

^a UNIVERSITY OF STIRLING   (United Kingdom)

^b BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Detection; Interpersonal relationships; Men's cancers; Prostate cancer; Prostate cancer incidence; Survival

Indexed keywords

AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CLINICAL ARTICLE; COHORT ANALYSIS; COMORBIDITY; DATA ANALYSIS; HEALTH PROMOTION; HELP SEEKING BEHAVIOR; HUMAN; MALE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITATIVE RESEARCH; SEMI STRUCTURED INTERVIEW; SOCIAL NETWORK;

AGED; FAMILY; HEALTH PROMOTION; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INTERPERSONAL RELATIONS; MALE; MASCULINITY; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PRIMARY HEALTH CARE; PROSTATIC NEOPLASMS; QUALITATIVE RESEARCH; SEXUAL PARTNERS;

EID: 84896033447     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-013-1989-y     Document Type: Article

References (37)

1. ISD Scotland (2010) Cancer of the male genital organs 2003-2007: incidence by NHS Board Area of Residence, Scotland. http://www.isdscotland.org/ Health-Topics/Cancer/Cancer-Statistics/Male-Genital-Organs/#prostate. NHS National Services Scotland. Ref type: electronic citation. Accessed 28 Sep 2013
2. ISD Scotland (2009) Cancer in Scotland (2009) Edinburgh, NHS National Services Scotland. Ref type: report
3. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18(3):581-591
4. National Cancer Institute UNIoH (2010) Age-adjusted SEER incidence rates and trends for the top 15 cancer sites by race/ethnicity. National Cancer Institute UNIoH, editor. SEER Cancer Statistics Review 1975-2007. Surveillance Epidemiology and End Results (SEER). Bethesda, MD. Ref type: generic
5. American Cancer Society (2012) Cancer facts and figures 2012. http://bit.ly/xB1A2s. Accessed 26 Sept 2012
6. Cancer Research UK (2010) Prostate cancer - UK incidence statistics. http://info.cancerresearchuk.org/cancerstats/types/prostate/incidence/#trends. Viewed October 2010
7. Mistry M, Parkin DM, Ahmad AS, Sasieni P (2011) Cancer incidence in the United Kingdom: projections to the year 2030. Br J Cancer 105:1795-1803
8. Ablin RJ, Haythorn MR (2009) Screening for prostate cancer: controversy? what controversy? Curr Oncol 16(3):142-143
9. Barry MJ (2009) Screening for prostate cancer - the controversy that refuses to die. N Engl J Med 360(13):1351-1354
10. Schroeder FH, Hugosson J, Roobol MJ, Tammela TLJ, Ciatto S, Nelen V et al (2009) Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360(13):1320-1328
11. Gatta G, Capocaccia R, Sant M, Bell CM, Coebergh JW, Damhuis RA et al (2000) Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut Int J Gastroenterol Hepatol 47(4):533-538
12. Sant M, Allemani C, Capocaccia R, Hakulinen T, Aareleid TCJ et al (2003) Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 106:416-422 (Pubitemid 36870406)
13. Andersen BL, Cacioppo JT, Roberts DC (1995) Delay in seeking a cancer diagnosis: delay stages and psychophysiological comparison processes. Br J Soc Psychol 34(1):33-52
14. Walter F, Webster A, Scott S, Emery J (2011) The Andersen Model of total patient delay: a systematic review of its application in cancer diagnosis. J Health Service Res Policy 17(2):110-118
15. Fitzpatrick P, Corcoran N, Fitzpatrick JM (1998) Prostate cancer: how aware is the public? Br J Urol 82(1):43-48 (Pubitemid 28316668)
16. Hevey D, Pertl M, Thomas K, Maher L, Chuinneagain SN, Craig A (2009) The relationship between prostate cancer knowledge and beliefs and intentions to attend PSA screening among at-risk men. Patient Educ Couns 74(2):244-249
17. Bratt O, Damber JE, Emanuelsson M, Kristoffersson U, Lundgren R, Olsson H et al (2000) Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer. EJC 36(2):235-241 (Pubitemid 30102201)
18. Forbat L, Place M, Kelly D, Hubbard G, Boyd K, Howie K et al (2012) A cohort study reporting clinical risk factors and individual risk perceptions of prostate cancer: implications for PSA testing. Br J Urol Int 111(3):389-395
19. Smith LK, Pope C, Botha JL (2005) Patients' help-seeking experiences and delay in cancer presentation: a qualitative synthesis. Lancet 366(9488):825-831 (Pubitemid 41557382)
20. George A, Flemming P (2004) Factors affecting men's help-seeking in the early detection of prostate cancer: implications for health promotion. J Men's Health Gender 1(4):345-352 (Pubitemid 40486021)
21. Ndubuisi SC, Kofie VY, Andoy JY et al (1995) Black-white differences in the stage at presentation of prostate cancer in the District of Columbia. Urology 46:71-77
22. Krongrad A, Lai H, Burke MA et al (1996) Marriage and mortality in prostate cancer. J Urol 156:1696-1700
23. Tyson M, Andrews P, Etzioni D, et al. (2012) Marital status and prostate cancer outcomes. American Urological Association Annual Meeting. 19-5-2012. Ref type: conference proceeding
24. Seymour-Smith S, Wetherell M, Pheonix A (2002) 'My wife ordered me to come!': a discursive analysis of doctors' and nurses' accounts of men's use of general practitioners. J Health Psychol 7(3):253-267 (Pubitemid 34532790)
25. Courtenay WH (2005) Constructions of masculinity and their influence onmen's well-being: a theory of gender and health. Soc Sci Med 50:1385-1401
26. O'Brien R, Hunt K, Hart G (2005) 'It's caveman stuff, but that is to a certain extent how guys still operate': men's accounts of masculinity and help seeking. Soc Sci Med 61(3):503-516 (Pubitemid 40724597)
27. Nicholas DR (1990)Men, masculinity and cancer: risk-factor behaviours, early detection and psychosocial adaptation. J Am Coll Health 49(1):27-33
28. Creswell JW, Plano Clark VL (2006) Designing and conducting mixed methods research. Sage, London
29. Irvine A, Drew P, Sainsbury R (2012) 'Am I not answering your questions properly?': clarification, adequacy and responsiveness in semi-structured telephone and face-to-face interviews. Qual Health Res. doi:10.1177/ 1468794112439086
30. James ND, Sydes MR, Clarke NW, Mason MD, Dearnaley DP, Anderson J et al (2009) Systemic therapy for advancing or metastatic prostate cancer (STAMPEDE): a multi-arm, multistage randomized controlled trial. Br J Urol Int 103(4):464-469
31. Ritchie J, Spencer L (1994) Qualitative data analysis for applied policy research. In: Bryman A, Burgess RG (eds) Analysing qualitative data. Routledge, London, pp 173-194
32. Young JM, Muscatello DJ, Ward JE (2000) Are men with lower urinary tract symptoms at increased risk of prostate cancer?A systematic review and critique of the available evidence. Brit Jn Urol Int 85:1037-1048 (Pubitemid 30348795)
33. Illingworth N, Forbat L, Hubbard G, Kearney N (2010) The importance of relationships in the experience of cancer: a re-working of the policy ideal of whole-systems working. Eur J Oncol Nurs 14(1):23-28
34. Chamie K, Kwan L, Connor SE, Zavala M, Labo J, Litwin MS (2012) The impact of social networks and partnership status on treatment choice in men with localized prostate cancer. Br J Urol Int 109(7):1006-1012
35. Campbell C (2001) Social capital and health: contextualising health promotion within local community networks. In: Baron S, Field J, Schuller T (eds) Social capital: critical perspectives. Oxford University Press, Oxford, pp 182-196
36. Mathew AG, Paradiso C, Currie KL, Finelli A, Hartman M et al (2011) Examining risk perception among men with a family history of prostate cancer. Patient Educ Couns 85(2):251-257
37. Boehmer UE, Clark JA (2001) Married couples' perspectives on prostate cancer diagnosis and treatment decision-making. Psycho-Oncology 10(2):147-155